Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.
The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.
Anterix Inc. (ATEX) filed a Form 3 for its Chief Financial Officer, reporting initial beneficial ownership as of 09/22/2025. The CFO holds 7,028 shares of common stock, which include Restricted Stock Units: 877 shares vesting on May 15, 2026; 672 shares vesting on July 12, 2026; and 3,925 shares vesting in three equal annual installments beginning October 4, 2025.
The filing also lists a stock option for 3,680 shares at an exercise price of $40, expiring on 04/03/2035, vesting in three equal annual installments beginning October 4, 2025.
Anterix Inc. (ATEX) reported an initial statement of beneficial ownership. A company officer filed Form 3 effective 09/17/2025, disclosing 34,578 shares of common stock held directly. The filer is identified as an Officer (Chief Marketing Officer) and Chief of Staff. The filing also notes Restricted Stock Units that will vest in three equal installments beginning on September 9, 2026.
Anterix Inc. disclosed that on October 3, 2025 it entered into a bonus agreement with Chief Regulatory and Communications Officer Christopher Guttman-McCabe. The company paid a one-time bonus of $500,000 on October 8, 2025 for his work supporting operations and strategy. The payment is subject to a clawback: if Mr. Guttman-McCabe leaves before October 3, 2027, he must repay the bonus. The agreement includes customary covenants and the company will file the full agreement as an exhibit in its periodic report for the quarter ended December 31, 2025.
Lang Scott A., President, CEO and Director of Anterix Inc. (ATEX), reported a personal purchase of company stock. On 09/18/2025 he acquired 4,650 shares of Common Stock at $21.28 per share and after the transaction beneficially owned 4,650 shares directly. The Form 4 was filed by one reporting person and was signed by an attorney-in-fact on the same date.
Lang Scott A., President, CEO and Director of Anterix Inc. (ATEX), reported a personal purchase of company stock. On 09/18/2025 he acquired 4,650 shares of Common Stock at $21.28 per share and after the transaction beneficially owned 4,650 shares directly. The Form 4 was filed by one reporting person and was signed by an attorney-in-fact on the same date.
Anterix, Inc. (ATEX) disclosed a Chief Financial Officer transition: Timothy A. Gray resigned as CFO effective September 19, 2025, and the Board appointed Elena Marquez as CFO effective September 22, 2025. Ms. Marquez, age 39, has served as Vice President of Finance and Controller since September 2021 and previously held senior finance roles at Clinical Genomics and Prudential Financial. In connection with her promotion, she will receive additional restricted stock units with an aggregate grant date fair value of $250,000 vesting in three equal annual installments and will be eligible to participate in the Company’s Executive Severance Plan. The Board designated her as the company’s principal financial officer and principal accounting officer for SEC purposes. The filing notes standard indemnification and states there are no related-party or Item 404 transactions to disclose.
Anterix, Inc. (ATEX) disclosed a Chief Financial Officer transition: Timothy A. Gray resigned as CFO effective September 19, 2025, and the Board appointed Elena Marquez as CFO effective September 22, 2025. Ms. Marquez, age 39, has served as Vice President of Finance and Controller since September 2021 and previously held senior finance roles at Clinical Genomics and Prudential Financial. In connection with her promotion, she will receive additional restricted stock units with an aggregate grant date fair value of $250,000 vesting in three equal annual installments and will be eligible to participate in the Company’s Executive Severance Plan. The Board designated her as the company’s principal financial officer and principal accounting officer for SEC purposes. The filing notes standard indemnification and states there are no related-party or Item 404 transactions to disclose.
Insider transaction summary: Anterix Inc. (ATEX) Chief Financial Officer Timothy Gray reported a purchase of 50 shares of the issuer's common stock on 08/19/2025 at a price of $22.07 per share. Following the purchase, Mr. Gray beneficially owns 77,022 shares in a direct capacity. The Form 4 was signed by an attorney-in-fact on 08/20/2025.
Anterix Inc.'s Schedule 13G discloses that DG Capital Management, LLC and its managing member, Dov Gertzulin, report beneficial ownership of 975,739 shares of Anterix common stock, representing 5.2% of the class based on 18,695,874 shares outstanding. The reported Shares are held by private investment funds and separately managed accounts for which DG Capital serves as investment manager and include shares that can be acquired upon exercise of options.
Both reporting persons state they have no sole voting or dispositive power and instead have shared voting and dispositive power over the 975,739 shares. The filing disclaims beneficial ownership except to the extent of any pecuniary interest and certifies the securities were acquired and are held in the ordinary course of business.
Anterix Inc. reported a net income of $25.18 million for the quarter ended June 30, 2025, reversing a prior-year loss of $15.52 million. Revenue from spectrum leases was $1.418 million, slightly below $1.525 million a year earlier. The swing to profit was driven primarily by a $33.9 million non-cash gain on exchange of intangible assets recorded when the company received broadband licenses for 62 counties, plus $1.0 million of gains on sales of licenses.
On the balance sheet, cash and cash equivalents were $41.4 million and total assets were $359.6 million. Deferred revenue stood at $128.2 million and revenue allocated to remaining performance obligations was $180.1 million, to be recognized over terms up to 30 years. Intangible assets increased to $265.3 million, reflecting license acquisitions and exchanges. The company reported $35.9 million in current liabilities, including contingent liabilities tied to customer deposits and license delivery obligations, and noted $227.7 million remaining under its $250.0 million share repurchase authorization.
Anterix Inc. announced its first quarter fiscal 2026 financial results for the three months ended June 30, 2025 and released an update on its Demonstrated Intent key performance indicator. The company furnished an earnings release and the KPI update as Exhibits 99.1 and 99.2, which are available on its investor website.
The materials were furnished rather than filed, so the 8-K text itself does not include financial figures or operating metrics. Readers must consult the attached exhibits or the investor website for the detailed results and metric values; the 8-K states these exhibits are not incorporated by reference into other filings.
Form 4 filing summary – Anterix Inc. (ATEX): On 08/05/2025, director and 10 % owner Jeffrey A. Altman accepted 7,767 restricted shares of ATEX common stock as non-employee director compensation (code “A”) at a $0 acquisition cost. The award vests on the earlier of 05 Aug 2026 or the next annual shareholder meeting, subject to insider-trading blackout rules.
Following the grant, Altman’s direct holdings rise to 15,416 shares. He also reports 124,492 additional directly held shares and 5,411,776 shares held indirectly via Owl Creek funds, leaving the Owl Creek/Altman group comfortably above the 10 % ownership threshold. No sales, option exercises, or derivative trades were reported, so overall economic exposure remains largely unchanged. The transaction is routine, modest in size relative to Altman’s existing 5.55 million-share exposure, and has limited impact on Anterix’s ownership structure or float.